Bristol-Myers Squibb Company (BMY)

Jan 15, 2025, 10:56 AM EST - 2 days ago

Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug

Jan 13, 2025, 7:58 PM EST - 4 days ago

Feedback on schizophrenia treatment has been great, says Bristol Myers Squibb CEO

Jan 13, 2025, 2:00 PM EST - 4 days ago

Bristol-Myers Squibb Company (BMY) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Jan 13, 2025, 7:00 AM EST - 4 days ago

ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors

Jan 9, 2025, 6:28 AM EST - 8 days ago

Buy 6 'Safer' Dividend Dogs Of 23 January Barron's Better Bets Than T-Bills

BBY CAG EQR FRT KEY KIM LYB

Jan 8, 2025, 11:13 AM EST - 9 days ago

Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market

AMGN BBIO IOVA LLY MDGL MRK PFE

Jan 3, 2025, 12:06 PM EST - 14 days ago

Healthcare has 'been so bad, maybe it's gonna be good' in 2025, says Mizuho's Jared Holz

ABT HOLX LLY NVO UNH XBI XLV

Jan 3, 2025, 6:59 AM EST - 14 days ago

Bristol Myers Squibb to Present at J.P. Morgan's 43rd Annual Healthcare Conference

Jan 2, 2025, 6:17 PM EST - 15 days ago

Final Trade: XLE, PANW, XHB, BMY

XLE PANW XHB

Dec 31, 2024, 7:05 AM EST - 17 days ago

Drugmakers to raise US prices on over 250 medicines starting Jan. 1

PFE SNY

Dec 30, 2024, 12:30 PM EST - 18 days ago

Bristol-Myers Squibb Stock: Clearly Undervalued, Excellent 2H24 Culminates In Opdivo 'Subcu' Approval

Dec 27, 2024, 5:37 PM EST - 21 days ago

U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy) Injection, for Subcutaneous Use in Most Previously Approved Adult, Solid Tumor Opdivo® (nivolumab) Indications1,2

Dec 27, 2024, 11:35 AM EST - 21 days ago

US FDA approves injectable form of Bristol Myers' Opdivo

Dec 23, 2024, 6:59 AM EST - 25 days ago

Bristol Myers Squibb Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu (deucravacitinib) in Adults with Psoriatic Arthritis

Dec 23, 2024, 6:45 AM EST - 25 days ago

Bristol Myers Squibb Receives European Commission Approval for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer

Dec 20, 2024, 2:00 PM EST - 4 weeks ago

Bristol-Myers Squibb: Rich Dividends & Double-Digits Upside Potential - Bright 2026 Prospects

Dec 20, 2024, 8:00 AM EST - 4 weeks ago

Bristol-Myers Squibb Will Handle The Patent Cliff And Is Still Undervalued

Dec 19, 2024, 8:30 AM EST - 4 weeks ago

Imbed Biosciences Appoints Bristol Myers Squibb Veteran Terry Bromley as Chief Executive Officer

Dec 19, 2024, 6:59 AM EST - 4 weeks ago

Bristol Myers Squibb to Report Results for Fourth Quarter 2024 on February 6, 2025

Dec 19, 2024, 1:48 AM EST - 4 weeks ago

BioArctic announces global license agreement with Bristol Myers Squibb for BioArctic's PyroGlutamate-amyloid-beta antibody program

Dec 18, 2024, 11:40 PM EST - 4 weeks ago

Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare

Dec 18, 2024, 9:00 AM EST - 4 weeks ago

Bristol-Myers: Still An Opportunity Yielding Over 4%

Dec 17, 2024, 8:19 AM EST - 4 weeks ago

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

ABBV CVS

Dec 11, 2024, 4:17 PM EST - 5 weeks ago

Bristol Myers Squibb Announces Dividend Increase

Dec 9, 2024, 5:45 PM EST - 5 weeks ago

Bristol Myers Squibb Highlights Progress of Cell Therapy Portfolio at ASH 2024 with Long-Term Survival Data and Results from Expanding Pipeline

Dec 9, 2024, 11:19 AM EST - 5 weeks ago

Bristol Myers A Top Socially Responsible Dividend Stock With 4% Yield

Dec 7, 2024, 9:40 AM EST - 5 weeks ago

Buy 3 December Barron's Better Bet 'Safer' Dividend Dogs Of 23

BBY CAG EQR ETR FRT KEY KIM

Dec 3, 2024, 10:39 AM EST - 6 weeks ago

Bristol-Myers Squibb Company (BMY) Citi's 2024 Global Healthcare Conference (Transcript)

Dec 3, 2024, 8:00 AM EST - 6 weeks ago

AI Proteins Announces Research Collaboration and Option Agreement with Bristol Myers Squibb for Miniprotein-Based Therapeutics Valued up to $400M

Dec 3, 2024, 7:39 AM EST - 6 weeks ago

Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 4% Dividend Yields

ABBV PDCO

Nov 27, 2024, 2:00 PM EST - 7 weeks ago

Calls of the Day: Martin Marietta, Datadog, Bristol-Myers, Eli Lilly and Disney

DDOG DIS LLY MLM

Nov 27, 2024, 5:00 AM EST - 7 weeks ago

BMY Stock vs. JNJ Stock

JNJ

Nov 26, 2024, 6:59 AM EST - 7 weeks ago

Bristol Myers Squibb to Participate in Citi's 2024 Global Healthcare Conference

Nov 26, 2024, 5:10 AM EST - 7 weeks ago

Prime Medicine's Bristol Myers Partnership Boosts Outlook For Gene Editing Therapies

PRME

Nov 25, 2024, 3:47 PM EST - 7 weeks ago

5 Reasons Bristol-Myers Squibb Looks Good Now (Rating Upgrade)

Nov 23, 2024, 9:00 AM EST - 7 weeks ago

Potential $5,000 Monthly Income: 10 Investments To Buy And Hold For Next 10 Years

AAPL ADX AVGO BLK COP CSCO CVX

Nov 19, 2024, 4:05 PM EST - 2 months ago

Bristol-Myers Squibb Company (BMY) Jefferies London Healthcare Conference (Transcript)

Nov 19, 2024, 6:59 AM EST - 2 months ago

Bristol Myers Squibb's Presentations at ASH 2024 Reinforce Strength of Hematology Portfolio and Scientific Advances in Differentiated Research Platforms

Nov 18, 2024, 1:24 PM EST - 2 months ago

Encouraging Early Data From Next-Gen Study Puts Bristol Myers' CAR T Therapy In The Spotlight For Autoimmune Diseases

Nov 17, 2024, 11:47 AM EST - 2 months ago

Bristol-Myers Squibb: Buy This Bargain Before It's Gone

Nov 15, 2024, 8:23 AM EST - 2 months ago

Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite Instability–High or Mismatch Repair Deficient Metastatic Colorectal Cancer

Nov 15, 2024, 6:59 AM EST - 2 months ago

Bristol Myers Squibb Receives Positive CHMP Opinion for Repotrectinib for the Treatment of Advanced ROS1-Positive Non-Small Cell Lung Cancer and Advanced NTRK-Positive Solid Tumors

Nov 14, 2024, 6:49 PM EST - 2 months ago

Bristol Myers faces renewed, $6.7 bln lawsuit over delayed cancer drug

Nov 12, 2024, 12:48 PM EST - 2 months ago

Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock

Nov 12, 2024, 8:53 AM EST - 2 months ago

AbbVie's disappointing schizophrenia drug trial bodes well for rival Bristol Myers, analysts say

ABBV

Nov 12, 2024, 7:22 AM EST - 2 months ago

Buy, Sell, Or Hold BMY Stock?

Nov 11, 2024, 4:08 PM EST - 2 months ago

Bristol-Myers Squibb Company (BMY) Guggenheim Securities Inaugural Healthcare Innovation Conference (Transcript)

Nov 11, 2024, 11:00 AM EST - 2 months ago

Bristol Myers Squibb's stock soars after rival AbbVie reports disappointing schizophrenia-drug trial

Nov 11, 2024, 10:27 AM EST - 2 months ago

AbbVie Stock Slips As $9 Billion Schizophrenia Studies Flunk, Bristol-Myers Stock Surges

ABBV

Nov 11, 2024, 6:59 AM EST - 2 months ago

Bristol Myers Squibb Showcases the Continued Strength of its Cardiovascular Portfolio with New Clinical and Real-World Data at American Heart Association Scientific Sessions 2024